Cholestasis as a liver protective factor in paracetamol acute overdose
- 1 November 1995
- journal article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 26 (7) , 1619-1624
- https://doi.org/10.1016/0306-3623(95)00061-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Changes in liver drug glucuronidation during cholestasis are non predictableArchives Internationales de Physiologie, de Biochimie et de Biophysique, 1994
- Glucuronidation and its Role in Regulation of Biological Activity of DrugsAnnual Review of Pharmacology and Toxicology, 1992
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Effects of Liver Disease on the Disposition of Ciramadol in HumansThe Journal of Clinical Pharmacology, 1989
- Protein and lipid disturbances in rat liver microsomal membranes after bile duct ligationBiochemical and Biophysical Research Communications, 1987
- The effects of age and chronic liver disease on the elimination of temazepamEuropean Journal of Clinical Pharmacology, 1986
- Liver microsomal bilirubin UDP-Glucuronyltransferase disturbances in bile duct ligated ratsBiochemical and Biophysical Research Communications, 1985
- Acetaminophen-induced hepatotoxicityLife Sciences, 1981
- Effects of aging and liver disease on disposition of lorazepamClinical Pharmacology & Therapeutics, 1978
- Acetaminophen-induced Hepatic NecrosisPharmacology, 1974